project id: TCGA-BRCA; case submitter id: TCGA-GM-A5PV; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.42; rna integrity number: 8.2; age at index: 63; days to birth: -23215; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1948; age at diagnosis: 23215; ajcc pathologic m: M0; ajcc pathologic n: N1a; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 412.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8520/3; primary diagnosis: Lobular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 499; initial weight: 190.0; oct embedded: false; preservation method: Unknown; sample id: da53d0eb-95fd-466a-a7aa-6251cb4ce408; sample submitter id: TCGA-GM-A5PV-01A; portion id: fc831f84-6344-44f9-8f5d-b21053b33fc7; portion submitter id: TCGA-GM-A5PV-01A-11; slide id: 108695f7-6c19-41c9-9a63-abd78088f235; slide submitter id: TCGA-GM-A5PV-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 75.0; percent stromal cells: 10.0; percent tumor cells: 15.0; percent tumor nuclei: 65.0; section location: TOP;